Gadoterate Meglumine 65219-0084-15

Package NDC

65219-0084-15

Manufacturer: Fresenius Kabi Usa, Llc
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: June 20, 2022
Listing Expires: December 31, 2026
Application: ANDA215304

Need to source Gadoterate Meglumine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Gadoterate Meglumine	376.9 mg/mL

Drug Class

Gadolinium-based Contrast Agent [EPC]Magnetic Resonance Contrast Activity [MoA]

Selected Package

65219-0084-15Selected

10 CARTON in 1 BOX (65219-084-15) / 1 VIAL in 1 CARTON (65219-084-01) / 15 mL in 1 VIAL